Research Roundup

Debbie Rigby takes a look at the latest in research news Oral antivirals for mild–moderate COVID‑19: a panacea or a logistical and clinical conundrum? Multiple therapeutic options for COVID-19 are now available. These include parenteral anti-spike protein monoclonal antibodies (sotrovimab, casirivimab/ imdevimab), oral antivirals (nirmatrelvir/ritonavir, molnupiravir) and parenteral antivirals (remdesivir). Among the new oral drugs,